Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Signs MOU with Taiwan ITRI

6 Aug 2007 07:00

ViaLogy PLC06 August 2007 Date: 6 August 2007 On behalf of: ViaLogy plc ("ViaLogy" or "the Company") Embargoed until: 0700hrs ViaLogy plc Signs Memorandum of Understanding with Taiwan's Industrial Technology Research Institute London, 6 August, 2007 - ViaLogy plc (LSE: VIY), a leading innovator ofreal-time network-centric signal processing platforms, today announces that ithas signed a memorandum of understanding (MOU) with Taiwan's IndustrialTechnology Research Institute (ITRI) to integrate its products, SPMTM andMicroSPMTM, with sensor systems developed by ITRI spin-out companies for uses insafety, security, surveillance and infrastructure management. SPMTM provides a standards-based, sensor-policy engine for managing large-scalenetworks of distributed sensors and systems, including building managementsystems, energy planning and physical security. SPM software allows automatedanalysis, alerting of appropriate personnel and rapid response. MicroSPMTMoffers a high speed hardware platform for fully-autonomous incident-based rapiddetection, analysis and response for sensor and video processing. Using thistechnology, ITRI's products can be enabled to interact rapidly with othernetworked subsystems which support a range of communication protocols. Founded in 1973, ITRI has played a vital role in Taiwan's economic success.Notable ITRI spin-off companies include United Microelectronics Corporation(UMC), the Taiwan Semiconductor Manufacturing Corporation (TSMC), and theVanguard International Semiconductor Company (VIS). Backed by its broadresearch scope and close industrial ties, ITRI is a leader in the globalindustrial R&D community. ITRI has signed research alliances with leadingforeign companies and universities such as Lucent Technologies, Microsoft, MITand the University of California, Berkeley. Michael Kelly, President and CEO of ViaLogy's US subsidiary, commented: "Thiscollaboration is a strategic one for ViaLogy. ITRI has a reputation forcreatively adapting foreign industrial processes to address identified needs andusing these technologies to help its spin-out companies become competitive inworld markets. In today's knowledge-based economy, we believe this cooperationwith ITRI will help position SPM as a comprehensive sensor interoperabilitysolution and service delivery platform for various industries and applicationsacross Asia." Dr. John Mai, ViaLogy's Manager for RFID Platforms, said: "ITRI hasrelationships with the major technology-related businesses in Taiwan. Thiscollaboration will accelerate adoption of SPMTM for large-scale industrialapplications. We are already working on integrating innovative sensor solutionsbeing developed at ITRI to quickly expand and scale up its installed-user base." Dr. Wu Chi Ho, Director of the Power Control and Sensing Application TechnologyDivision, of the Energy and Environmental Research Laboratories within ITRI,commented: "We believe ViaLogy's SPMTM and MicroSPMTM platforms presentexciting solutions to fill gaps in our development and commercialisationprocess. Their IP-enabled sensor interoperability software offers us a path torapidly bring our infrastructure monitoring projects to enterprise-level endusers in the oil and energy market sectors, both within Taiwan andinternationally. "ViaLogy's ability to add new sensors and support new network interoperabilityprotocols within 72 hours is very attractive for our scaling requirements." For further information please contact: ViaLogyMichael Kelly, CEO - US +1 626-296-6337Terry Bond, Chairman - UK & Europe +44 (0)20 7869 7014 Redleaf CommunicationsEmma Kane / Samantha Robbins +44 (0)20 7822 0200 Seymour Pierce LimitedMark Percy +44 (0)20 107 8000 About ITRI: The Industrial Technology Research Institute of Taiwan ITRI is a global, non-profit R&D organisation, engaged in applied research andindustrial services. Founded in 1973, ITRI played a vital role in Taiwan'seconomic success and is leading industrial research to transform Taiwan'seconomy from a manufacturing-based one to that of service- and knowledge- based.Backed by its broad research scope and close industrial ties, ITRI is becomingan increasingly active member in the global industrial R&D community. About ViaLogy: Network Centric Signal Processing. ViaLogy is a leading innovator of network-centric, real-time signal processingplatforms for sensor applications. ViaLogy is currently deploying and designingcomputational systems, powered by its patented technologies, for applications inlife sciences, public safety and security, surveillance, defense andgeoseismology. Vialogy focuses on market driven problems where automation,timeliness, quality and reliability of information processing are essential.ViaLogy's core competency incorporates rapidly and accurately detecting weaksignals buried in high noise background and clutter. This technology can beemployed to solve problems involving sensor integration and information overloadchallenges involving video, telephony and control sensors, as well as forenhancement of numerous signal processing applications. For more information,visit our website at www.vialogy.com. Except for statements of historical fact, the information presented hereinconstitutes forward-looking statements within the meaning of the PrivateSecurities Litigation Reform Act of 1995. Such forward-looking statementsinvolve known and unknown risks, uncertainties and other factors which may causethe actual results, performance or achievements of the company to be materiallydifferent from any future results, performance or achievements expressed orimplied. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
1st Apr 201912:12 pmRNSHolding(s) in Company
25th Mar 20197:00 amRNSYourgene raises IONA® test awareness in Egypt
26th Feb 20193:21 pmRNSHolding(s) in Company
22nd Feb 201910:00 amEQSHardman & Co Research: Yourgene Health (YGEN): EBITDA-positive in fiscal 2020
22nd Feb 20198:05 amRNSHolding(s) in Company
19th Feb 20192:21 pmRNSHolding(s) in Company
19th Feb 20197:15 amEQSHardman & Co Research: Yourgene Health (YGEN): Transformed and de-risked
18th Feb 201910:59 amRNSIssue of Equity
18th Feb 20197:00 amRNSMajor Capital & Commercial Restructuring
8th Jan 20197:00 amRNSYourgene launches Sage 32 plex
3rd Dec 20187:00 amRNSHalf-year Results
7th Nov 20187:00 amRNSChange of Name to Yourgene Health plc
5th Nov 201811:24 amRNSShare Transfer
2nd Nov 20187:00 amRNSDirectorate Change
25th Oct 20183:30 pmRNSResult of AGM
25th Oct 20187:00 amRNSHolding(s) in Company
25th Oct 20187:00 amRNSAGM Statement
22nd Oct 20187:00 amRNSFurther re: Fundraise
12th Oct 20181:15 pmRNSAvailability of Research Commentary
12th Oct 20187:00 amRNSTrading Update and Notice of Results
5th Oct 20187:00 amRNSDirector's dealing and share option issue
4th Oct 20187:00 amRNS$1 million collaboration agreement
3rd Oct 20187:00 amRNSDirectorate change
2nd Oct 20187:00 amRNSNotice of AGM
1st Oct 201812:20 pmRNSResult of Fundraise
28th Sep 20185:41 pmRNSProposed fundraise to raise approximately £2.5m
28th Sep 20185:40 pmRNSFull year results and half-year trading update
25th Sep 201811:31 amRNSHolding(s) in Company
21st Sep 20184:10 pmRNSHolding(s) in Company
21st Sep 20187:00 amRNSHolding(s) in Company
20th Sep 20189:30 amRNSSenior Appointment & Anticipated Director Change
19th Sep 201811:05 amRNSSecond Price Monitoring Extn
19th Sep 201811:00 amRNSPrice Monitoring Extension
19th Sep 20187:00 amRNSLegal Settlement & Licence Agreement with Illumina
11th Sep 20187:00 amRNSHolding(s) in Company
7th Aug 201810:57 amRNSHolding(s) in Company
12th Jul 20187:00 amRNSShare option awards
4th Jul 20187:00 amRNSBoard Changes
26th Jun 20181:31 pmRNSCollaboration with Abnova
13th Jun 20187:00 amRNSOutstanding NIPS Solution Provider Award Win
11th Jun 20187:00 amRNSDNA sequencing technology development agreement
7th Jun 20183:44 pmRNSHolding(s) in Company
5th Jun 20187:00 amRNSPremaitha signs partnership agreement in India
4th Jun 201811:05 amRNSHolding(s) in Company
24th May 20187:00 amRNSHolding(s) in Company
18th May 20184:38 pmRNSHolding(s) in Company
18th May 201812:06 pmRNSHolding(s) in Company
18th May 201812:05 pmRNSHolding(s) in Company
18th May 20189:40 amRNSHoldings in Company
15th May 20187:00 amRNSPremaitha expands footprint with new laboratories

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.